News

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...
Panelist discusses how new all-oral combination regimens are transforming the treatment landscape by addressing unmet needs ...
Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML ...
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body mass while still trimming pounds.
Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines.
Oncology, a team of expert scientists specializing in immuno-oncology extensively outlined the complexities involved in the ...
BSTR is being formed to catalyze the fusion of Bitcoin and capital markets . The Company’s mandate is to accumulate Bitcoin, generate in-kind Bitcoin yield, and advise corporates and sovereigns on ...
In this Healio Video Perspective, Cynthia Matossian, MD, FACS, and David Evans, PhD, MBA, discuss how to increase patient interest in elective lifestyle and cosmetic ophthalmic procedures now that ...
A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...
--Arvinas, Inc., a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today presented data from preclinical combination studies of ...
After the announcement, Sequans' stock (SQNS) climbed over 43% in 24 hours, peaking at $1.81 pre-market. By contrast, Bitcoin ...